These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14724969)

  • 1. [The autoimmune theory of the pathogenesis of atherosclerosis and related new treatment ways].
    Klimov AN; Nagornev VA; Denisenko AD; Konstantinov VO
    Vestn Ross Akad Med Nauk; 2003; (12):29-34. PubMed ID: 14724969
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of tactivin for treating patients with IHD].
    Klimov AN; Almazov VA; Nagornev VA; Denisenko AD; Pigarevskiĭ PV; Ogurtsov RP; Sergeeva EG; Sitnikova OD; Popov VG
    Ter Arkh; 1995; 67(9):24-7. PubMed ID: 7495034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary autoimmune syndrome and immunomodulating lymphotropic therapy in acute pancreatitis].
    Zaĭrat'iants OV; Kolobov SV; Iarema IV; Shevchenko VP
    Arkh Patol; 2002; 64(6):51-6. PubMed ID: 12534231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the effectiveness of immunomodulating preparations in combined therapy of chronic obstructive bronchitis].
    Shilov VA; Shirinskiĭ VS
    Klin Med (Mosk); 1995; 73(4):88-90. PubMed ID: 7474838
    [No Abstract]   [Full Text] [Related]  

  • 5. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the efficacy of topical and subcutaneous administration of tactivin for correcting secondary immunodeficiencies of young children].
    Arion VIa; Bekman EM; Tiurin NA; Mazurina NA; Filimonova AV
    Biull Eksp Biol Med; 1994 Nov; 118(11):496-8. PubMed ID: 7888649
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
    Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
    Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chronic liver diseases: secondary thymic insufficiency and immunocorrection with T-activin].
    Sarkisian SV
    Klin Med (Mosk); 1994; 72(6):45-8. PubMed ID: 7898010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoimmune processes in patients with different forms of the clinical course of ischemic heart disease].
    Mkhitarian LS; Kornilina EM; Dubrovskaia GV; Babov KD
    Lik Sprava; 1992 Mar; (3):12-5. PubMed ID: 1413674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunocorrective drugs in the combined treatment of autoimmune diseases of the thyroid gland].
    Balabolkin MI; Petunina NA; Sakaeva NA
    Klin Med (Mosk); 1993; 71(6):44-6. PubMed ID: 8145503
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of T-activin and thymalin in the treatment of ophthalmic herpes].
    Mal'khanov VB; Gripas' IA; Nasibullina GKh; Belousova MA
    Vestn Oftalmol; 1991; 107(5):51-4. PubMed ID: 1763455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological aspects of atherosclerosis].
    Osipov SG
    Klin Med (Mosk); 1989 Jan; 67(1):27-37. PubMed ID: 2654462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of T-activin and prodigiozan in combined treatment of patients with diabetic retinopathy].
    Sakalo EA; Malyzhev VA; Danilova AI
    Oftalmol Zh; 1988; (4):204-7. PubMed ID: 3263597
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immunomodulating therapy of rheumatoid arthritis].
    Balabanova RM; Barakat B
    Revmatologiia (Mosk); 1990; (3):38-44. PubMed ID: 2151541
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficacy of immunomodulating therapy in rheumatoid arthritis].
    Bassam B; Balabanova RM
    Ter Arkh; 1990; 62(5):32-5. PubMed ID: 2204139
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prospects of using immunocorrective treatment with an active thymus factor (taktivin) in dermatology].
    Skripkin IuK; Korotkiĭ NG; Udzhukhu VIu; Arion VIa; Eletskiĭ AIu
    Vestn Dermatol Venerol; 1986; (4):4-7. PubMed ID: 3487189
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
    Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
    Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of immunological mechanisms in the pathogenesis of arteriosclerosis, stenocardia and myocardial infarct].
    Ananchenko VG; Gulevich NV; Griaznova NA; Iurazh VIa
    Sov Med; 1980; (4):77-81. PubMed ID: 7384885
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immune complexes and arteriosclerosis].
    Osipov SG; Titov VN
    Kardiologiia; 1982; 22(7):119-25. PubMed ID: 6213809
    [No Abstract]   [Full Text] [Related]  

  • 20. [T-activin in multimodal treatment of systemic lupus erythematosus in children].
    Kartasheva VI; Tarasova LR; Zaĭrat'iants OV; Belokrinitskiĭ DV
    Pediatriia; 1991; (3):47-52. PubMed ID: 2047179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.